161 related articles for article (PubMed ID: 37860916)
1. Elucidating the role of blood metabolites on pancreatic cancer risk using two-sample Mendelian randomization analysis.
Zhong H; Liu S; Zhu J; Xu TH; Yu H; Wu L
Int J Cancer; 2024 Mar; 154(5):852-862. PubMed ID: 37860916
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.
Lu Y; Gentiluomo M; Lorenzo-Bermejo J; Morelli L; Obazee O; Campa D; Canzian F
J Med Genet; 2020 Dec; 57(12):820-828. PubMed ID: 32066631
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a causal link between intra-pancreatic fat deposition and pancreatic cancer: A prospective cohort and Mendelian randomization study.
Yamazaki H; Streicher SA; Wu L; Fukuhara S; Wagner R; Heni M; Grossman SR; Lenz HJ; Setiawan VW; Le Marchand L; Huang BZ
Cell Rep Med; 2024 Feb; 5(2):101391. PubMed ID: 38280379
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolites and risk of seven cancers: a two-sample Mendelian randomization study among European descendants.
Chen Y; Xie Y; Ci H; Cheng Z; Kuang Y; Li S; Wang G; Qi Y; Tang J; Liu D; Li W; Yang Y
BMC Med; 2024 Mar; 22(1):90. PubMed ID: 38433226
[TBL] [Abstract][Full Text] [Related]
5. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization.
King SD; Veliginti S; Brouwers MCGJ; Ren Z; Zheng W; Setiawan VW; Wilkens LR; Shu XO; Arslan AA; Beane Freeman LE; Bracci PM; Canzian F; Du M; Gallinger SJ; Giles GG; Goodman PJ; Haiman CA; Kogevinas M; Kooperberg C; LeMarchand L; Neale RE; Visvanathan K; White E; Albanes D; Andreotti G; Babic A; Berndt SI; Brais LK; Brennan P; Buring JE; Rabe KG; Bamlet WR; Chanock SJ; Fuchs CS; Gaziano JM; Giovannucci EL; Hackert T; Hassan MM; Katzke V; Kurtz RC; Lee IM; Malats N; Murphy N; Oberg AL; Orlow I; Porta M; Real FX; Rothman N; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Wang X; Wentzensen N; Yu H; Zeleniuch-Jacquotte A; Yu K; Wolpin BM; Duell EJ; Li D; Hung RJ; Perdomo S; McCullough ML; Freedman ND; Patel AV; Peters U; Riboli E; Sund M; Tjønneland A; Zhong J; Van Den Eeden SK; Kraft P; Risch HA; Amundadottir LT; Klein AP; Stolzenberg-Solomon RZ; Antwi SO
Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1265-1269. PubMed ID: 37351909
[TBL] [Abstract][Full Text] [Related]
6. Associations between genetically predicted levels of blood metabolites and pancreatic cancer risk.
Zhong H; Liu S; Zhu J; Wu L
Int J Cancer; 2023 Jul; 153(1):103-110. PubMed ID: 36757187
[TBL] [Abstract][Full Text] [Related]
7. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.
Xiao G; He Q; Liu L; Zhang T; Zhou M; Li X; Chen Y; Chen Y; Qin C
J Transl Med; 2022 Oct; 20(1):475. PubMed ID: 36266699
[TBL] [Abstract][Full Text] [Related]
8. Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study.
Chen S; Zhou Z; Zhou Z; Liu Y; Sun S; Huang K; Yang Q; Guo Y
Front Endocrinol (Lausanne); 2024; 15():1307944. PubMed ID: 38737546
[TBL] [Abstract][Full Text] [Related]
9. Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study.
Liu S; Ding D; Liu F; Guo Y; Xie L; Han FJ
J Ovarian Res; 2024 Jan; 17(1):22. PubMed ID: 38263045
[TBL] [Abstract][Full Text] [Related]
10. Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study.
Zhao G; Cai Y; Wang Y; Fang Y; Wang S; Li N
J Gene Med; 2024 May; 26(5):e3691. PubMed ID: 38757222
[TBL] [Abstract][Full Text] [Related]
11. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study.
Li X; Liang Z
J Cell Mol Med; 2024 Apr; 28(8):e18255. PubMed ID: 38526030
[TBL] [Abstract][Full Text] [Related]
12. Strengthening the Evidence for a Causal Link between Type 2 Diabetes Mellitus and Pancreatic Cancer: Insights from Two-Sample and Multivariable Mendelian Randomization.
Ke TM; Lophatananon A; Muir KR
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731833
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the causal effects of blood metabolites on irritable bowel syndrome: Mendelian randomization.
Zeng Y; Liu H; Pei Z; Li R; Liu Z; Liao C
BMC Gastroenterol; 2024 Jan; 24(1):19. PubMed ID: 38182988
[TBL] [Abstract][Full Text] [Related]
14. Causal effects of genetically determined metabolites on androgenetic alopecia: A two-sample Mendelian randomization analysis.
Du Y; Lu C; Bi L; Wang C; Zhao M; Ding Y; Fan W
Skin Res Technol; 2024 May; 30(5):e13732. PubMed ID: 38747971
[TBL] [Abstract][Full Text] [Related]
15. Human blood metabolites and risk of sepsis: A Mendelian randomization investigation.
Shang W; Qian H; Zhang S; Yuan M; Pan X; Huang S; Liu J; Chen D
Eur J Clin Invest; 2024 Apr; 54(4):e14145. PubMed ID: 38041600
[TBL] [Abstract][Full Text] [Related]
16. No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.
Yuan G; Yang M; Xie J; Xu K; Zhang F
Clin Rheumatol; 2023 Dec; 42(12):3237-3249. PubMed ID: 37495778
[TBL] [Abstract][Full Text] [Related]
17. Assessment of causal effects of visceral adipose tissue on risk of cancers: a Mendelian randomization study.
Lu Y; Tang H; Huang P; Wang J; Deng P; Li Y; Zheng J; Weng L
Int J Epidemiol; 2022 Aug; 51(4):1204-1218. PubMed ID: 35218345
[TBL] [Abstract][Full Text] [Related]
18. Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study.
Jiang Z; Mou Y; Wang H; Li L; Jin T; Wang H; Liu M; Jin W
BMC Cancer; 2023 Nov; 23(1):1091. PubMed ID: 37950180
[TBL] [Abstract][Full Text] [Related]
19. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
[No Abstract] [Full Text] [Related]
20. Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.
Yun Z; Guo Z; Li X; Shen Y; Nan M; Dong Q; Hou L
Cancer Med; 2023 Jun; 12(12):13784-13799. PubMed ID: 37132247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
